COMBINED CHEMOTHERAPY FOR RECURRENT AND METASTATIC NASOPHARYNGEAL CARCINOMA

被引：8
|
作者：
AIROLDI, M
PEDANI, F
GABRIELE, P
GIORDANO, C
CAVALOT, A
BRANDO, V
机构：
来源：
JOURNAL OF CHEMOTHERAPY | 1989年 / 1卷 / 04期
关键词：
D O I：
10.1080/1120009X.1989.11738907
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：272 / 276
页数：5
相关论文
共 50 条
  • [1] Maintenance metronomic chemotherapy for recurrent/metastatic nasopharyngeal carcinoma
    Wu, C.
    Wang, W. Y.
    Twu, C. W.
    Lin, P. J.
    Liu, Y. C.
    Lin, J. C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S515 - S515
  • [2] Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma
    Twu, Chih-Wen
    Lin, Po-Ju
    Tsou, Hsiao-Hui
    Liu, Yi-Chun
    Jiang, Rong-San
    Liang, Kai-Li
    Lin, Tian-Yun
    Wang, Wen-Yi
    Lin, Jin-Ching
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (06): : 1453 - 1461
  • [3] Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma
    You, Rui
    Zou, Xiong
    Ding, Xi
    Zhang, Wei-Jing
    Zhang, Meng-Xia
    Wang, Xiao
    Xu, Han-Shi
    Liu, Yong-Long
    Ouyang, Yan-Feng
    Duan, Chong-Yang
    Gu, Chen-Mei
    Wang, Zhi-Qiang
    Liu, You-Ping
    Hua, Yi-Jun
    Huang, Pei Yu
    Chen, Ming-Yuan
    MED, 2022, 3 (10): : 664 - +
  • [4] CHEMOTHERAPY OF METASTATIC AND OR RECURRENT UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA WITH CISPLATIN, BLEOMYCIN, AND FLUOROURACIL
    BOUSSEN, H
    CVITKOVIC, E
    WENDLING, JL
    AZLI, N
    BACHOUCHI, M
    MAHJOUBI, R
    KALIFA, C
    WIBAULT, P
    SCHWAAB, G
    ARMAND, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) : 1675 - 1681
  • [5] PD-1 inhibitors combined with chemotherapy versus chemotherapy alone: efficacy and prognostic analysis in recurrent metastatic nasopharyngeal carcinoma
    Liu, Yong
    Wang, Zhongxun
    Wu, Bo
    Zhu, Yinglan
    Liang, Xuzhong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (06): : 2622 - 2632
  • [6] Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
    Liu, Xin
    Shen, Hui
    Zhang, Lu
    Huang, Wenhui
    Zhang, Shuixing
    Zhang, Bin
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [7] Palliative Chemotherapy and Targeted Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma: Reminiscences and the Future
    Lee, V. H. F.
    Kwong, D. L. W.
    HONG KONG JOURNAL OF RADIOLOGY, 2013, 16 (04): : 252 - 260
  • [8] Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
    Huang, Luo
    Sim, Adelene Y. L.
    Wu, Yongzhong
    Liang, Zhongguo
    Li, Kaiguo
    Du, Youqin
    Ong, Enya H. W.
    Tan, Hong Qi
    Wee, Joseph T. S.
    Xie, Yue
    Shu, Xiaolei
    Wang, Ying
    Chua, Melvin L. K.
    Zhu, Xiaodong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [9] Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China
    Zhao, Ziying
    Chen, Tongfeng
    Zhou, Zhen
    Guo, Rui
    Liu, Qiao
    BMJ OPEN, 2023, 13 (12):
  • [10] Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update
    Jin, Ting
    Jiang, Feng
    Jin, Qi-Feng
    Piao, Yong-Feng
    Chen, Xiao-Zhong
    TRANSLATIONAL ONCOLOGY, 2018, 11 (02): : 286 - 291
12345